• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于语音的阿尔茨海默病研究的生物标志物。

Speech-Based Digital Biomarkers for Alzheimer's Research.

机构信息

ki:elements GmbH, Saarbrücken, Germany.

出版信息

Methods Mol Biol. 2024;2785:299-309. doi: 10.1007/978-1-0716-3774-6_18.

DOI:10.1007/978-1-0716-3774-6_18
PMID:38427201
Abstract

Digital biomarkers are of growing interest in the field of Alzheimer's Disease (AD) research. Digital biomarker data arising from digital health tools holds various potential benefits: more objective and more accurate assessment of patients' symptoms and remote collection of signals in real-world scenarios but also multimodal variance for prediction models of individual disease progression. Speech can be collected at minimal patient burden and provides rich data for assessing multiple aspects of AD pathology including cognition. However, the operations around collecting, preparing, and validly interpreting speech data within the context of clinical research on AD remains complex and sometimes challenging. Through a dedicated pipeline of speech collection tools, preprocessing steps and algorithms, precise qualification and quantification of an AD patient's pathology can be achieved from their speech. The aim of this chapter is to describe the methods that are needed to create speech collection scenarios that result in valuable speech-based digital biomarkers for clinical research.

摘要

数字生物标志物在阿尔茨海默病(AD)研究领域越来越受到关注。来自数字健康工具的数字生物标志物数据具有多种潜在的好处:更客观、更准确地评估患者的症状,并在现实场景中远程收集信号,但也为个体疾病进展的预测模型提供了多模态方差。语音可以以最小的患者负担采集,并为评估 AD 病理的多个方面提供丰富的数据,包括认知。然而,在 AD 临床研究背景下收集、准备和有效解释语音数据的操作仍然复杂,有时甚至具有挑战性。通过专门的语音采集工具、预处理步骤和算法管道,可以从患者的语音中精确地定性和定量分析 AD 患者的病理。本章的目的是描述创建语音采集场景的方法,这些场景可为临床研究产生有价值的基于语音的数字生物标志物。

相似文献

1
Speech-Based Digital Biomarkers for Alzheimer's Research.基于语音的阿尔茨海默病研究的生物标志物。
Methods Mol Biol. 2024;2785:299-309. doi: 10.1007/978-1-0716-3774-6_18.
2
Longitudinal observational cohort study: Speech for Intelligent cognition change tracking and DEtection of Alzheimer's Disease (SIDE-AD).纵向观察性队列研究:用于智能认知变化跟踪和阿尔茨海默病检测的言语研究(SIDE-AD)。
BMJ Open. 2024 Mar 28;14(3):e082388. doi: 10.1136/bmjopen-2023-082388.
3
Screening over Speech in Unselected Populations for Clinical Trials in AD (PROSPECT-AD): Study Design and Protocol.在未选择的 AD 临床研究人群中进行言语筛查 (PROSPECT-AD):研究设计和方案。
J Prev Alzheimers Dis. 2023;10(2):314-321. doi: 10.14283/jpad.2023.11.
4
Remote data collection speech analysis and prediction of the identification of Alzheimer's disease biomarkers in people at risk for Alzheimer's disease dementia: the Speech on the Phone Assessment (SPeAk) prospective observational study protocol.远程数据采集语音分析和预测阿尔茨海默病风险人群中阿尔茨海默病痴呆生物标志物的识别:电话评估语音(SPeAk)前瞻性观察研究方案。
BMJ Open. 2022 Mar 15;12(3):e052250. doi: 10.1136/bmjopen-2021-052250.
5
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.了解疾病进展和改善阿尔茨海默病临床试验:阿尔茨海默病神经影像学倡议的最新重点。
Alzheimers Dement. 2019 Jan;15(1):106-152. doi: 10.1016/j.jalz.2018.08.005. Epub 2018 Oct 13.
6
Alzheimer's in the modern age: Ethical challenges in the use of digital monitoring to identify cognitive changes.现代阿尔茨海默病:使用数字监测识别认知变化的伦理挑战。
Inform Health Soc Care. 2024 Jan 2;49(1):1-13. doi: 10.1080/17538157.2023.2294203. Epub 2023 Dec 20.
7
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.NIA-AA 研究框架:迈向阿尔茨海默病的生物学定义。
Alzheimers Dement. 2018 Apr;14(4):535-562. doi: 10.1016/j.jalz.2018.02.018.
8
Screening for Mild Cognitive Impairment Using a Machine Learning Classifier and the Remote Speech Biomarker for Cognition: Evidence from Two Clinically Relevant Cohorts.使用机器学习分类器和远程语音认知生物标志物筛查轻度认知障碍:来自两个临床相关队列的证据。
J Alzheimers Dis. 2023;91(3):1165-1171. doi: 10.3233/JAD-220762.
9
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials.阿尔茨海默病中的 Tau 生物标志物:迈向临床实践和试验的应用。
Lancet Neurol. 2022 Aug;21(8):726-734. doi: 10.1016/S1474-4422(22)00168-5. Epub 2022 May 25.
10
Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum.开发一种用于临床前阿尔茨海默病的智能手机筛查测试,并在整个痴呆症连续体中进行验证。
BMC Neurol. 2024 Apr 16;24(1):127. doi: 10.1186/s12883-024-03609-z.

引用本文的文献

1
From "invisible" to "audible": Features extracted during simple speech tasks classify patient-reported fatigue in multiple sclerosis.从“不可见”到“可听出”:在简单言语任务中提取的特征可对多发性硬化症患者自述的疲劳进行分类。
Mult Scler. 2025 Feb;31(2):231-241. doi: 10.1177/13524585241303855. Epub 2024 Dec 17.

本文引用的文献

1
Validation of the Remote Automated ki:e Speech Biomarker for Cognition in Mild Cognitive Impairment: Verification and Validation following DiME V3 Framework.用于轻度认知障碍认知的远程自动化语音生物标志物的验证:遵循DiME V3框架的验证与确认
Digit Biomark. 2022 Sep 30;6(3):107-116. doi: 10.1159/000526471. eCollection 2022 Sep-Dec.
2
Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research.阿尔茨海默病疾病修饰治疗试验失败的原因及其在近期研究中的作用。
Biomedicines. 2019 Dec 9;7(4):97. doi: 10.3390/biomedicines7040097.
3
Exploitation vs. exploration-computational temporal and semantic analysis explains semantic verbal fluency impairment in Alzheimer's disease.
挖掘与探索——计算时-语义分析阐释阿尔茨海默病患者语义流畅性损害
Neuropsychologia. 2019 Aug;131:53-61. doi: 10.1016/j.neuropsychologia.2019.05.007. Epub 2019 May 20.
4
Use of Speech Analyses within a Mobile Application for the Assessment of Cognitive Impairment in Elderly People.在移动应用程序中使用语音分析评估老年人认知障碍
Curr Alzheimer Res. 2018;15(2):120-129. doi: 10.2174/1567205014666170829111942.
5
Alzheimer's disease drug-development pipeline: few candidates, frequent failures.阿尔茨海默病药物研发管线:候选药物寥寥,失败频频。
Alzheimers Res Ther. 2014 Jul 3;6(4):37. doi: 10.1186/alzrt269. eCollection 2014.
6
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.阿尔茨海默病病理生理过程的追踪:动态生物标志物的更新假设模型。
Lancet Neurol. 2013 Feb;12(2):207-16. doi: 10.1016/S1474-4422(12)70291-0.